Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Nov 11, 2016

Sanofi and Regeneron to Present Data from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2016
Mar 30, 2016

Sanofi and Regeneron to Present Phase 3 Praluent^® (alirocumab) Injection Clinical Trial Data at ACC.16
Mar 16, 2016

Sanofi and Regeneron Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal
Mar 4, 2016

Sanofi and Regeneron Announce Humana Provides Exclusive or Preferred Access to Praluent® (alirocumab) Injection on Their Commercial and Medicare Formularies

Praluent is now covered by most health insurance and Medicare plans
Feb 23, 2016

Sanofi US to Return Auvi-Q® (epinephrine injection, USP) Rights to kaléo
- Photos 1

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.